Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/18/2025

Treatment of Costochondritis

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

  • The American College of Rheumatology recommends selecting an NSAID based on a patient's past history of NSAID use, risk factors for adverse effects, and comorbidities, with no specific NSAID preferred for treating costochondritis 1
  • Any NSAID can be effective for treating costochondritis, with multiple head-to-head controlled trials showing no evidence to suggest that indomethacin has different effects on pain or stiffness compared to other NSAIDs 1
  • The European Association of Urology recommends ibuprofen as the first-line treatment for managing pain, with a recommended dosing of 400-800mg three times daily for 7-10 days 2

NSAID Selection and Dosing

  • Ibuprofen can be used at a maximum daily dose of 2400-3200mg, according to the Journal of the National Comprehensive Cancer Network 3
  • Naproxen provides more sustained relief with twice-daily dosing (500mg BID) and may be considered as an alternative to ibuprofen due to its lesser interference with aspirin's cardioprotective effects 4, 2
  • Acetaminophen (paracetamol) can be used as an alternative up to 3000 mg daily, divided into 3-4 doses, with a lower maximum dose recommended for patients with a history of alcoholism 5
  • Meloxicam may be preferred over ibuprofen for patients with increased gastrointestinal risk due to its better GI safety profile at equivalent therapeutic doses, as recommended by the European League Against Rheumatism 6, 4

COX-2 Selective Inhibitors and Gastroprotection

  • COX-2 selective inhibitors like celecoxib decrease the risk of developing gastrointestinal clinical events and complications by approximately 50% compared to non-selective NSAIDs, particularly for patients at higher risk of GI complications, as recommended by the American Gastroenterological Association 7
  • A proton pump inhibitor (PPI) should be added to NSAID therapy for patients with age >65 years, history of peptic ulcer disease, concomitant use of aspirin, anticoagulants, or corticosteroids, or need for high-dose or prolonged NSAID therapy, to reduce the risk of GI complications 8, 7, 9

Monitoring and Follow-up

  • Patients should be assessed for pain relief after 3-5 days, and if no improvement is seen after 7 days, alternative treatments should be considered, according to the European Association of Urology guidelines 2
  • Clinical reassessment at 2-4 weeks to evaluate efficacy is crucial, and blood pressure check within 1-2 weeks of starting therapy is also recommended 10
  • Patients should be monitored for adverse effects, and gastroprotection should be considered, especially when using NSAIDs, as recommended by the European Association of Urology 2

Special Considerations

  • Patients with a history of alcoholism should be advised to minimize or eliminate alcohol consumption, as alcohol significantly increases NSAID-associated GI bleeding risk, and avoid using multiple NSAIDs simultaneously 11
  • The American Heart Association notes that ibuprofen may interfere with aspirin's ability to irreversibly acetylate platelet COX-1 enzyme, potentially reducing aspirin's protective effect against atherothrombotic events, and therefore naproxen is preferred for patients with cardiovascular risk factors 12
  • For elderly patients or those with GI risk factors, add gastroprotection (PPI) with either NSAID and consider the lowest effective dose for the shortest duration, according to the American Heart Association 12
  • Liver function tests should be performed at baseline and periodically due to alcoholism history, and renal function monitoring is also important, especially with alcohol history 13, 14

Guideline Recommendations

  • The American College of Rheumatology recommends naproxen 500 mg twice daily as the preferred NSAID therapy for patients with severe arthritis and a history of alcoholism, with gastroprotection using a proton pump inhibitor, due to its sustained symptomatic relief and cardiovascular safety profile 5, 13
  • The European Association of Urology guidelines support the use of NSAIDs, such as ibuprofen, for pain management in urological conditions, due to their effectiveness in reducing inflammation and providing adequate pain relief, with a well-established safety profile when used appropriately 2

REFERENCES

3

adult cancer pain. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

13

nsaid prescribing precautions. [LINK]

American family physician, 2009